Emerald Advisers, LLC Sarepta Therapeutics, Inc. Transaction History

Emerald Advisers, LLC

$2.41 Billion
Q3 2024

A detailed history of Emerald Advisers, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Emerald Advisers, LLC holds 8,338 shares of SRPT stock, worth $952,449. This represents 0.04% of its overall portfolio holdings.

Number of Shares

8,338

Previous 4,279 94.86%

Holding current value

$952,449

Previous $676,000 53.99%

% of portfolio

0.04%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$124.33 - $156.75 $504,655 - $636,248	4,059 Added 94.86%	8,338 $1.04 Million
Q2 2024 Aug 06, 2024	BUY	$113.33 - $163.85 $274,938 - $397,500	2,426 Added 130.92%	4,279 $676,000
Q1 2024 May 08, 2024	BUY	$93.7 - $141.53 $173,626 - $262,255	1,853 New	1,853 $239,000
Q3 2023 Oct 26, 2023	SELL	$102.5 - $123.59 $7,380 - $8,898	-72 Reduced 2.04%	3,454 $418,000
Q2 2023 Jul 25, 2023	SELL	$106.4 - $157.19 $937,809 - $1.39 Million	-8,814 Reduced 71.43%	3,526 $403,000
Q1 2023 May 04, 2023	SELL	$117.53 - $155.99 $405,243 - $537,853	-3,448 Reduced 21.84%	12,340 $1.7 Million
Q4 2022 Feb 03, 2023	SELL	$100.86 - $132.13 $32,779 - $42,942	-325 Reduced 2.02%	15,788 $2.05 Million
Q3 2022 Oct 25, 2022	BUY	$75.71 - $119.24 $936,456 - $1.47 Million	12,369 Added 330.37%	16,113 $1.78 Million
Q2 2022 Jul 29, 2022	BUY	$62.69 - $88.44 $234,711 - $331,119	3,744 New	3,744 $281,000
Q1 2021 Apr 29, 2021	SELL	$72.25 - $168.95 $770,907 - $1.8 Million	-10,670 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$125.56 - $178.74 $42,690 - $60,771	-340 Reduced 3.09%	10,670 $1.82 Million
Q3 2020 Oct 28, 2020	BUY	$127.12 - $172.34 $47,161 - $63,938	371 Added 3.49%	11,010 $1.55 Million
Q2 2020 Jul 28, 2020	SELL	$93.0 - $171.7 $261,888 - $483,507	-2,816 Reduced 20.93%	10,639 $1.71 Million
Q1 2020 Apr 30, 2020	SELL	$82.38 - $131.64 $11,862 - $18,956	-144 Reduced 1.06%	13,455 $1.32 Million
Q4 2019 Jan 29, 2020	BUY	$76.53 - $135.58 $185,661 - $328,917	2,426 Added 21.71%	13,599 $1.76 Million
Q3 2019 Oct 31, 2019	BUY	$72.81 - $156.91 $80,091 - $172,601	1,100 Added 10.92%	11,173 $842,000
Q2 2019 Jul 31, 2019	SELL	$112.21 - $151.95 $5.02 Million - $6.8 Million	-44,753 Reduced 81.63%	10,073 $1.53 Million
Q1 2019 May 01, 2019	SELL	$106.67 - $151.68 $2.3 Million - $3.28 Million	-21,607 Reduced 28.27%	54,826 $6.54 Million
Q4 2018 Jan 30, 2019	SELL	$97.32 - $148.76 $13.5 Million - $20.6 Million	-138,715 Reduced 64.47%	76,433 $8.34 Million
Q3 2018 Oct 31, 2018	SELL	$115.31 - $161.51 $9.71 Million - $13.6 Million	-84,196 Reduced 28.13%	215,148 $34.7 Million
Q2 2018 Jul 31, 2018	SELL	$71.74 - $153.69 $7.52 Million - $16.1 Million	-104,804 Reduced 25.93%	299,344 $39.6 Million
Q1 2018 Apr 26, 2018	SELL	$54.02 - $82.27 $26.1 Million - $39.7 Million	-482,831 Reduced 54.44%	404,148 $29.9 Million
Q4 2017 Feb 05, 2018	SELL	$47.64 - $56.75 $309,898 - $369,158	-6,505 Reduced 0.73%	886,979 $49.4 Million
Q3 2017 Oct 30, 2017	BUY	$35.73 - $47.15 $31.9 Million - $42.1 Million	893,484	893,484 $40.5 Million

Others Institutions Holding SRPT

# of Institutions

531

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Advisers, LLC with notifications on news.

Account

Emerald Advisers, LLC Sarepta Therapeutics, Inc. Transaction History